Following the meeting on new drugs and regimens in Beijing, TB MAC has allocated up to $145,000 to fund 2 projects for “Modelling to support rational introduction of new drugs and regimens”. Applications are invited for four separate research areas, which can be found at Request for Applications on the TB MAC website.
Aim: To develop models that support the use and rational introduction of new drugs and regimens. Applications are invited to address the following modelling questions:
1. What is the optimal allocation of a limited resource to the control of MDR TB?
2. Application of models to maximize the probability of success in phase 3 clinical trials of new drug regimens
3. Assessing the health outcomes and economic consequences of different strategies for scale-up of novel regimens
4. Modelling to Understand the Epidemiological Impact and Market Impact of Harmonized Regimens for MDR-TB
Applications are now invited, and will be processed quickly. The two successful applications will be notified in by 9th December.
Opening Date – 13th Oct 2013
Closing date – 10th Nov 2013
Please see the Request for Applications section on the Consortium website for more details, and how to submit an application.
